A significant shift in Canadian drug policy has occurred, as the government allow the availability of psilocybin fungi for therapeutic treatment. Until now, these substances were strictly restricted, but a mounting body of studies suggests they may offer aid for emotional illnesses like PTSD. This change represents a substantial step toward reconsi